Cognitive Profile of Patients at the Sagol Center for Hyperbaric Medicine and Research
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04287283|
Recruitment Status : Active, not recruiting
First Posted : February 27, 2020
Last Update Posted : February 27, 2020
In the investigator's institute there is ongoing treatment of different patients with cognitive deficits using Hyperbaric oxygen therapy (HBOT). These patients undergo neuro-cognitive function computerized tests before and after treatment.
The aim of this study was to retrospectively evaluate the cognitive changes before and after HBOT in different patients populations.
|Condition or disease||Intervention/treatment|
|TBI (Traumatic Brain Injury) Stroke Fibromyalgia Aging||Other: Hyperbaric Oxygen|
Retrospective analysis of patients suffering from chronic neuro-cognitive deficits due to different conditions, treated at Sagol center for hyperbaric medicine and research, Shamir (Assaf Harofeh) Medical Center, Israel
Patients included if they had at least two neurocognitive tests, before and after Hyperbaric Oxygen Therapy (HBOT). The study was approved by the institutional review board of the hospital.
Patients were treated with 40-60 daily hyperbaric sessions, 5 days per week. Each session consists of 90 minutes exposure to 100% oxygen at 1.5-2 ATA.
|Study Type :||Observational|
|Actual Enrollment :||2500 participants|
|Official Title:||The Profile of Cognitive Function of Patients Who Had Neurocognitive Evaluation at the Sagol Center for Hyperbaric Medicine and Research|
|Actual Study Start Date :||January 2008|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||January 2021|
Patients with chronic brain injury or cognitive complaints that have been treated with Hyperbaric oxygen therapy and underwent computerized cognitive tests before and after the treatment
Other: Hyperbaric Oxygen
40-60 daily hyperbaric sessions, 5 days per week. Each session consists of 90 minutes exposure to 100% oxygen at 1.5-2 ATA.
- Change in neurocognitive scores [ Time Frame: baseline and 12 weeks ]change in scores in a computerized neuro-cognitive test, "IQ-scale" score, normalized for age and education, with mean=100 and SD=15 points in healthy population, higher score implies better results.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04287283
|hyperbaric center Asaf harofe medical center|
|Rishon lezion, Israel|